Skip to content

Medpace Voice

Tag: Central Laboratory

Central Laboratories

Belgium Central Lab Expansion

  • January 3, 2020

As part of our efforts to expand laboratory services and capabilities, Medpace’s central lab in Belgium recently completed extensive expansions including a new modern laboratory…

Clinical Development

4 Key Considerations for Designing Immuno-Oncology Trials

  • July 22, 2019

As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…

Central Laboratories

The Current Biomarker Landscape in Immuno-Oncology

  • June 13, 2019

Dr. El Mustapha Bahassi, Associate Director of Clinical Laboratories at Medpace, highlights the biomarker landscape in immuno-oncology clinical research.

Clinical Development

Medpace Expansion Initiatives Across Europe

  • March 5, 2019

While the CRO industry has grown primarily through mergers and acquisitions, Medpace has expanded through disciplined organic growth – expanding globally to operations in 36…

Central Laboratories

Evaluating the Effect of Hemolysis, Icterus, and Lipemia on Chemistry Assays

  • December 19, 2018

Experts from Medpace’s central laboratory evaluated the effect of hemolysis, icterus and lipemia on chemistry assays and assessed the association between the amount of interfering…

Central Laboratories

Medpace Expands Production Capabilities for Collection Kits

  • September 5, 2018

As part of our mission to deliver superb customer service and site support, we have recently expanded our kit building capabilities in the US and…

Central Laboratories

Medpace’s Biorepository Services: Expansion and Highlights

  • August 31, 2018

In this post, we highlight some of the key investments we have made in each of our biorepositories around the world and what that means…

Central Laboratories

Molecular Capabilities and Genetic Laboratory Expansion

  • August 22, 2018

With the advancement of precision medicine, molecular and genetic testing is becoming a critical component for patient selection and individual assessment of the risks and…

Central Laboratories

Medpace Harmonizes Global Data across Its Regional Laboratories

  • October 17, 2017

Data from central laboratories have been key for assessing safety, tolerability, and efficacy of new drugs in clinical trials. With the increasing complexity and global…

Central Laboratories

Biomarkers for Celiac Disease Clinical Trials

  • October 2, 2017

As a full service, global CRO with an integrated central lab, Medpace has the scientific, operational and regulatory expertise to manage your celiac disease clinical…